Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL4169384

NCCCc1ccc2c(c1)c(=O)c(C(=O)O)cn2CCF.O=C(O)C(F)(F)F

nearest known ligand 0.46

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.46
KDM4E B2RXH2 4/20 0.44
HPGD P15428 2/20 0.44
HSD17B10 Q99714 2/20 0.44
TSHR P16473 1/20 0.44
RAB9A P51151 1/20 0.44
TOP1 P11387 1/20 0.41
LMNA P02545 2/20 0.41
HTT P42858 1/20 0.41
CNR2 P34972 1/20 0.40
DRD3 P35462 1/20 0.39
CYP1A2 P05177 1/20 0.39
CYP2D6 P10635 1/20 0.39
APEX1 P27695 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
CHRM1 P11229 1/20 0.39
PDE4A P27815 1/20 0.39
PDE4B Q07343 1/20 0.39
PDE4C Q08493 1/20 0.39
PDE4D Q08499 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL3982421 0.92 KDM4E (0.55) ALDH1A1KDM4EHPGDHSD17B10TSHR
Trifluoroacetic Acid SCHEMBL4180492 0.91 KDM4E (0.43) ALDH1A1KDM4EHPGDHSD17B10TSHR
Trifluoroacetic Acid SCHEMBL5428188 0.90 TPSAB1 (0.47) ALDH1A1KDM4EHPGDHSD17B10TSHR
Trifluoroacetic Acid SCHEMBL4180697 0.88 RXRA (0.44) ALDH1A1KDM4EHPGDHSD17B10TSHR
SCHEMBL5437272 0.85 KDM4E (0.60) ALDH1A1KDM4EHPGDHSD17B10TSHR
SCHEMBL4169392 0.85 LMNA (0.39) ALDH1A1KDM4EHPGDHSD17B10TSHR
SCHEMBL3976181 0.84 KDM4E (0.59) ALDH1A1KDM4EHPGDHSD17B10TSHR
SCHEMBL3976165 0.84 KDM4E (0.59) ALDH1A1KDM4EHPGDHSD17B10TSHR
Trifluoroacetic Acid SCHEMBL4171412 0.84 TOP1 (0.37) ALDH1A1KDM4EHPGDHSD17B10TSHR
Trifluoroacetic Acid SCHEMBL3288601 0.83 TOP1 (0.40) ALDH1A1KDM4EHPGDHSD17B10TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20090062218-A1 MACROLONE COMPOUNDS GLAXO GROUP LIMITED (GB) 2009-03-05 US disclosed
EP-1824871-A1 MACROLONE COMPOUNDS GLAXO GROUP LIMITED (GB) 2007-08-29 EP disclosed
WO-2006050940-A1 MACROLONE COMPOUNDS GLAXO GROUP LIMITED (GB) 2006-05-18 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090062218-A1 MACROLONE COMPOUNDS CYP51A1, MRPL21, MYD88 ALDH1A1 4011/4885KDM4E 3897/4885HPGD 2617/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.